| Product Code: ETC13258348 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Guanylate Cyclase-C Agonists Market was valued at USD 1.9 Billion in 2024 and is expected to reach USD 3.1 Billion by 2031, growing at a compound annual growth rate of 9.65% during the forecast period (2025-2031).
The Global Guanylate Cyclase-C Agonists Market is experiencing notable growth due to the increasing prevalence of gastrointestinal diseases such as irritable bowel syndrome and inflammatory bowel disease. Guanylate cyclase-C agonists, like linaclotide and plecanatide, have shown efficacy in treating these conditions by targeting the gastrointestinal tract. The market is also benefiting from the rising awareness about these therapies among healthcare professionals and patients. Furthermore, ongoing research and development activities aimed at expanding the indications for guanylate cyclase-C agonists are expected to drive market growth. However, challenges such as stringent regulatory requirements and competition from alternative treatment options may hinder the market`s progress. Overall, the Global Guanylate Cyclase-C Agonists Market is poised for steady expansion in the coming years.
The Global Guanylate Cyclase-C Agonists Market is experiencing significant growth due to the rising prevalence of gastrointestinal disorders such as colorectal cancer and irritable bowel syndrome. The market is witnessing a surge in research and development activities aimed at developing novel guanylate cyclase-C agonists for the treatment of these conditions, offering a promising outlook for market expansion. Furthermore, the increasing focus on personalized medicine and targeted therapies in the healthcare sector presents opportunities for the market players to capitalize on the growing demand for more effective and specific treatment options. Collaborations between pharmaceutical companies and research institutions to advance the development of guanylate cyclase-C agonists further contribute to the market`s growth potential. Overall, the Global Guanylate Cyclase-C Agonists Market is poised for continued advancement and innovation in the coming years.
One of the main challenges faced in the Global Guanylate Cyclase-C agonists market is the limited awareness and understanding of these drugs among healthcare professionals and patients. Despite the potential benefits of Guanylate Cyclase-C agonists in treating gastrointestinal disorders like irritable bowel syndrome and constipation, the relatively new nature of these drugs means that there is a lack of familiarity and confidence in their use. This can result in slower adoption rates and lower prescription rates, hindering the market growth potential. Additionally, the high cost of these medications compared to existing treatment options could pose a challenge in terms of market acceptance and affordability for patients. Education and awareness initiatives will be crucial in addressing these challenges and expanding the market for Guanylate Cyclase-C agonists.
The Global Guanylate Cyclase-C (GC-C) Agonists Market is primarily driven by the increasing prevalence of gastrointestinal diseases such as irritable bowel syndrome and constipation, which are major therapeutic indications for GC-C agonists. Additionally, the rising geriatric population worldwide, coupled with the growing awareness about the benefits of GC-C agonists in managing chronic digestive disorders, is fueling market growth. Moreover, the advancements in drug development and the introduction of novel GC-C agonists with improved efficacy and safety profiles are further propelling market expansion. Furthermore, the expanding research and development activities in the field of gastrointestinal health and the increasing investment by pharmaceutical companies in developing GC-C agonist-based therapies are contributing to the market`s growth trajectory.
Government policies related to the Global Guanylate Cyclase-C Agonists Market primarily revolve around regulatory approvals and market access. Regulatory bodies such as the FDA in the United States and the EMA in Europe play a crucial role in approving new drugs and ensuring their safety and efficacy. Additionally, government healthcare systems and insurance policies impact market access for Guanylate Cyclase-C agonists, influencing pricing, reimbursement, and patient access to these medications. Governments may also implement policies to encourage research and development in this market segment through funding initiatives or tax incentives. Overall, government policies in the Global Guanylate Cyclase-C Agonists Market aim to balance innovation, patient safety, and affordability to ensure the availability of effective treatments for patients in need.
The Global Guanylate Cyclase-C Agonists Market is expected to witness significant growth in the coming years, driven by the increasing prevalence of gastrointestinal diseases such as irritable bowel syndrome and chronic constipation. The growing awareness about the benefits of guanylate cyclase-C agonists in the treatment of these conditions, along with the rising adoption of novel therapies, is likely to propel market expansion. Additionally, ongoing research and development activities aimed at expanding the therapeutic applications of guanylate cyclase-C agonists are anticipated to further boost market growth. However, factors such as stringent regulatory requirements and the presence of alternative treatment options may pose challenges to market advancement. Overall, the Global Guanylate Cyclase-C Agonists Market is poised for steady growth, with opportunities for innovation and market penetration.
In the Global Guanylate Cyclase-C Agonists Market, Asia is projected to witness significant growth due to increasing healthcare expenditure and rising prevalence of gastrointestinal diseases. North America is expected to dominate the market, driven by advanced healthcare infrastructure and high adoption rates of innovative therapies. Europe is also a key market, characterized by a strong presence of pharmaceutical companies and growing awareness about gastrointestinal disorders. The Middle East and Africa region is likely to experience steady growth as healthcare systems continue to develop. Latin America shows potential for market expansion due to improving healthcare access and rising disposable incomes, leading to increased demand for effective treatments targeting gastrointestinal conditions. Overall, the global market for Guanylate Cyclase-C Agonists is poised for growth across all regions, with varying degrees of opportunity and challenges.
Global Guanylate Cyclase-C Agonists Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Guanylate Cyclase-C Agonists Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 & 2031F |
3.3 Global Guanylate Cyclase-C Agonists Market - Industry Life Cycle |
3.4 Global Guanylate Cyclase-C Agonists Market - Porter's Five Forces |
3.5 Global Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Drug, 2021 & 2031F |
3.7 Global Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Global Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.9 Global Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Global Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.11 Global Guanylate Cyclase-C Agonists Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Guanylate Cyclase-C Agonists Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Guanylate Cyclase-C Agonists Market Trends |
6 Global Guanylate Cyclase-C Agonists Market, 2021 - 2031 |
6.1 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Drug, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Trulance, 2021 - 2031 |
6.1.3 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Linzess, 2021 - 2031 |
6.2 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Application, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Irritable Bowel Syndrome, 2021 - 2031 |
6.2.3 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Chronic Idiopathic Constipation, 2021 - 2031 |
6.2.4 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Injection, 2021 - 2031 |
6.3.3 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Tablet, 2021 - 2031 |
6.3.4 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.4.3 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.4.4 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Others, 2021 - 2031 |
6.5 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.5.3 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.5.4 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.5.5 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Others, 2021 - 2031 |
6.6 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.6.3 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.6.4 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.6.5 Global Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Guanylate Cyclase-C Agonists Market, Overview & Analysis |
7.1 North America Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 - 2031 |
7.2 North America Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Drug, 2021 - 2031 |
7.4 North America Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Application, 2021 - 2031 |
7.5 North America Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
7.6 North America Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.7 North America Guanylate Cyclase-C Agonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
7.8 North America Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Guanylate Cyclase-C Agonists Market, Overview & Analysis |
8.1 Latin America (LATAM) Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Drug, 2021 - 2031 |
8.4 Latin America (LATAM) Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Application, 2021 - 2031 |
8.5 Latin America (LATAM) Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
8.6 Latin America (LATAM) Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.7 Latin America (LATAM) Guanylate Cyclase-C Agonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
8.8 Latin America (LATAM) Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Guanylate Cyclase-C Agonists Market, Overview & Analysis |
9.1 Asia Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Drug, 2021 - 2031 |
9.4 Asia Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Application, 2021 - 2031 |
9.5 Asia Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
9.6 Asia Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.7 Asia Guanylate Cyclase-C Agonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
9.8 Asia Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Guanylate Cyclase-C Agonists Market, Overview & Analysis |
10.1 Africa Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Drug, 2021 - 2031 |
10.4 Africa Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Application, 2021 - 2031 |
10.5 Africa Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
10.6 Africa Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.7 Africa Guanylate Cyclase-C Agonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
10.8 Africa Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Guanylate Cyclase-C Agonists Market, Overview & Analysis |
11.1 Europe Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Drug, 2021 - 2031 |
11.4 Europe Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Application, 2021 - 2031 |
11.5 Europe Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
11.6 Europe Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.7 Europe Guanylate Cyclase-C Agonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
11.8 Europe Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Guanylate Cyclase-C Agonists Market, Overview & Analysis |
12.1 Middle East Guanylate Cyclase-C Agonists Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Guanylate Cyclase-C Agonists Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Drug, 2021 - 2031 |
12.4 Middle East Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Application, 2021 - 2031 |
12.5 Middle East Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Dosage, 2021 - 2031 |
12.6 Middle East Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.7 Middle East Guanylate Cyclase-C Agonists Market, Revenues & Volume, By End-Users, 2021 - 2031 |
12.8 Middle East Guanylate Cyclase-C Agonists Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Guanylate Cyclase-C Agonists Market Key Performance Indicators |
14 Global Guanylate Cyclase-C Agonists Market - Export/Import By Countries Assessment |
15 Global Guanylate Cyclase-C Agonists Market - Opportunity Assessment |
15.1 Global Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Drug, 2021 & 2031F |
15.3 Global Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Application, 2021 & 2031F |
15.4 Global Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Dosage, 2021 & 2031F |
15.5 Global Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.6 Global Guanylate Cyclase-C Agonists Market Opportunity Assessment, By End-Users, 2021 & 2031F |
15.7 Global Guanylate Cyclase-C Agonists Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Guanylate Cyclase-C Agonists Market - Competitive Landscape |
16.1 Global Guanylate Cyclase-C Agonists Market Revenue Share, By Companies, 2024 |
16.2 Global Guanylate Cyclase-C Agonists Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here